From appendix of recent half year investor briefing: The ratio of incremental ACV generated by a sales team in period, compared to the direct costs obtaining that incremental ACV
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025